Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Propranolol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hemangioma 9 Hemangioma, Capillary 5 Melanoma 4 Sarcoma 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Hypertension, Portal 3 Hemangiosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Hepatocellular 3 Breast Neoplasms 3 Sarcoma, Kaposi 2 Ovarian Neoplasms 2 Hemangioma, Cavernous, Central Nervous System 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ulcer 1 Tuberous Sclerosis 1 Stomach Neoplasms 1 Spinal Cord Neoplasms 1 Smoldering Multiple Myeloma 1 Skin Neoplasms 1 Recurrent respiratory papillomatosis 1 Recurrence 1 Papilloma 1 Neuroblastoma 1 Neoplasms 1

Interventions

Cyclophosphamide 81 Etoposide 44 Temozolomide 37 Carboplatin 37 Filgrastim 36 Topotecan 35 Melphalan 35 Isotretinoin 35 Irinotecan 35 Vincristine 34 Doxorubicin 33 3-Iodobenzylguanidine 30 Granulocyte Colony-Stimulating Factor 26 Cisplatin 25 Peripheral Blood Stem Cell Transplantation 24 sargramostim 21 dinutuximab 21 Granulocyte-Macrophage Colony-Stimulating Factor 21 Radiotherapy 20 Busulfan 18 fludarabine 16 Magnetic Resonance Spectroscopy 16 naxitamab 14 aldesleukin 13 Thiotepa 13 Interleukin-2 13 fludarabine phosphate 12 humanized 3F8 anti-GD2 monoclonal antibody 11 etoposide phosphate 11 Biopsy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02641314 2024-05-10

METRO-NB2012

University of Cologne

Phase 2 Completed

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡